Clinical Trials Directory

Trials / Conditions / Stage IV Soft Tissue Sarcoma AJCC v7

Stage IV Soft Tissue Sarcoma AJCC v7

9 registered clinical trials studyying Stage IV Soft Tissue Sarcoma AJCC v7.

StatusTrialSponsorPhase
WithdrawnImmune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT03397186
Fred Hutchinson Cancer CenterPhase 2
CompletedSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H
NCT03213678
National Cancer Institute (NCI)Phase 2
CompletedTazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or
NCT03213665
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanc
NCT03155620
National Cancer Institute (NCI)Phase 2
CompletedRibociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B
NCT03009201
OHSU Knight Cancer InstitutePhase 1
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su
NCT02500797
National Cancer Institute (NCI)Phase 2
Active Not RecruitingRadiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi
NCT02180867
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedAlisertib in Treating Patients With Advanced or Metastatic Sarcoma
NCT01653028
National Cancer Institute (NCI)Phase 2
CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun
NCT01638533
National Cancer Institute (NCI)Phase 1